Yvan Arsenijevic
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Precision gene therapy: Tailoring rAAV-mediated gene therapies for inherited retinal dystrophies (IRDs).
Journal: Molecular aspects of medicine
Published: April 29, 2025
Exploring Histone Modifications in Inherited Retinal Disorders.
Journal: Advances in experimental medicine and biology
Published: February 10, 2025
Glutamylation imbalance impairs the molecular architecture of the photoreceptor cilium.
Journal: The EMBO journal
Published: July 29, 2024
Dual CRALBP isoforms unveiled: iPSC-derived retinal modeling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 15, 2024
Fine-tuning FAM161A gene augmentation therapy to restore retinal function.
Journal: EMBO molecular medicine
Published: January 10, 2024
Gene augmentation therapy attenuates retinal degeneration in a knockout mouse model of Fam161a retinitis pigmentosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 29, 2023
Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium.
Journal: International journal of molecular sciences
Published: July 28, 2021
Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy.
Journal: International journal of molecular sciences
Published: July 26, 2021
A new mouse model for retinal degeneration due to Fam161a deficiency.
Journal: Scientific reports
Published: August 25, 2020
Last Updated: 09/26/2026